Radionuclide Imaging in Parkinson’s Disease: Diagnosis, Treatment, and Disease Progression
Identifieur interne : 003185 ( Main/Exploration ); précédent : 003184; suivant : 003186Radionuclide Imaging in Parkinson’s Disease: Diagnosis, Treatment, and Disease Progression
Auteurs : Doris J. Doudet [Canada]Source :
- Journal of Pharmacy Practice [ 0897-1900 ] ; 2001-08.
Abstract
This paper reviews the abilities of positron emission tomography (PET) and single photon emission tomography (SPECT) to detect Parkinson’s disease, monitor its progression and the effect of therapy. It also provides insights on the role these two modalities provide in terms of discriminating atypical syndromes from Parkinson’s disease. Both PET and SPECT are sensitive means of detecting alterations in metabolism and blood flow in the brain and impairments in neurotransmitter function, especially dopaminergic, in the striatum and, more recently, in extrastriatal structures. To date, PET presents the added advantage of quantification, better sensitivity and resolution and a greater variety of tracers for both the dopaminergic and nondopaminergic systems.
Url:
DOI: 10.1106/76VR-VNP7-T1EW-6HGY
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C01
- to stream Istex, to step Curation: 000C01
- to stream Istex, to step Checkpoint: 001012
- to stream Main, to step Merge: 003665
- to stream Main, to step Curation: 003185
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Radionuclide Imaging in Parkinson’s Disease: Diagnosis, Treatment, and Disease Progression</title><author wicri:is="90%"><name sortKey="Doudet, Doris J" sort="Doudet, Doris J" uniqKey="Doudet D" first="Doris J." last="Doudet">Doris J. Doudet</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:AC45DABDF59E87F02CF8A847BC9B4BE7A0211051</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1106/76VR-VNP7-T1EW-6HGY</idno><idno type="url">https://api-v5.istex.fr/document/AC45DABDF59E87F02CF8A847BC9B4BE7A0211051/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000C01</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000C01</idno><idno type="wicri:Area/Istex/Curation">000C01</idno><idno type="wicri:Area/Istex/Checkpoint">001012</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001012</idno><idno type="wicri:doubleKey">0897-1900:2001:Doudet D:radionuclide:imaging:in</idno><idno type="wicri:Area/Main/Merge">003665</idno><idno type="wicri:Area/Main/Curation">003185</idno><idno type="wicri:Area/Main/Exploration">003185</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Radionuclide Imaging in Parkinson’s Disease: Diagnosis, Treatment, and Disease Progression</title><author wicri:is="90%"><name sortKey="Doudet, Doris J" sort="Doudet, Doris J" uniqKey="Doudet D" first="Doris J." last="Doudet">Doris J. Doudet</name><affiliation></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Canada</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Pharmacy Practice</title><idno type="ISSN">0897-1900</idno><idno type="eISSN">1531-1937</idno><imprint><publisher>Sage Publications</publisher><pubPlace>Sage CA: Thousand Oaks, CA</pubPlace><date type="published" when="2001-08">2001-08</date><biblScope unit="volume">14</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="341">341</biblScope><biblScope unit="page" to="350">350</biblScope></imprint><idno type="ISSN">0897-1900</idno></series><idno type="istex">AC45DABDF59E87F02CF8A847BC9B4BE7A0211051</idno><idno type="DOI">10.1106/76VR-VNP7-T1EW-6HGY</idno><idno type="ArticleID">10.1106_76VR-VNP7-T1EW-6HGY</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0897-1900</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This paper reviews the abilities of positron emission tomography (PET) and single photon emission tomography (SPECT) to detect Parkinson’s disease, monitor its progression and the effect of therapy. It also provides insights on the role these two modalities provide in terms of discriminating atypical syndromes from Parkinson’s disease. Both PET and SPECT are sensitive means of detecting alterations in metabolism and blood flow in the brain and impairments in neurotransmitter function, especially dopaminergic, in the striatum and, more recently, in extrastriatal structures. To date, PET presents the added advantage of quantification, better sensitivity and resolution and a greater variety of tracers for both the dopaminergic and nondopaminergic systems.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Doudet, Doris J" sort="Doudet, Doris J" uniqKey="Doudet D" first="Doris J." last="Doudet">Doris J. Doudet</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003185 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003185 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:AC45DABDF59E87F02CF8A847BC9B4BE7A0211051
|texte= Radionuclide Imaging in Parkinson’s Disease: Diagnosis, Treatment, and Disease Progression
}}
| This area was generated with Dilib version V0.6.29. |  |